Invention Grant
- Patent Title: Sterol derivative, preparation method therefor and use thereof
-
Application No.: US14376481Application Date: 2013-02-04
-
Publication No.: US10093695B2Publication Date: 2018-10-09
- Inventor: Zhenwen Duan , Shuren Guo , Xuemei Li
- Applicant: Beijing Peking University WBL Biotech Co., Ltd.
- Applicant Address: CN Beijing
- Assignee: BEIJING PEKING UNIVERSITY WBL BIOTECH CO., LTD.
- Current Assignee: BEIJING PEKING UNIVERSITY WBL BIOTECH CO., LTD.
- Current Assignee Address: CN Beijing
- Agency: Shumaker, Loop & Kendrick, LLP
- Agent James D. Miller
- Priority: CN201210023523 20120202; CN201210023584 20120202
- International Application: PCT/CN2013/071350 WO 20130204
- International Announcement: WO2013/113294 WO 20130808
- Main IPC: C07J71/00
- IPC: C07J71/00 ; A61K31/58 ; A61K36/88 ; A61K36/064 ; A61K31/357 ; A61K36/899

Abstract:
The present disclosure discloses a sterol derivative, a preparation method therefor and a use thereof. The sterol derivative includes a sterol compound with Structural Formula (I) or a pharmaceutically acceptable salt thereof, or an extract containing the sterol compound, or a composition containing the sterol compound, wherein Structural Formula (I) is as follows: where R1 is —OH, ═O, H or C1-C3 alkyl; R2 is —OH, H or C1-C3 alkyl; R3 is —OH, ═O, H or C1-C3 alkyl; R4 is —OH, H or C1-C3 alkyl, and at least one of R1, R2, R3 and R4 is —OH. The compound with Structural Formula (I) can be used for preparing a drug having inhibitory effect on 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity and the prepared drug can effectively inhibit the HMG-CoA reductase activity or be used for preparing an anti-cancer drug.
Public/Granted literature
- US20150025130A1 STEROL DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Public/Granted day:2015-01-22
Information query